On April 18th, at a sharing session on "Medical Insurance Departments Supporting Technological Innovation" organized by the National Healthcare Security Administration, Jiang Bingzhen, Director of the Medical Price Department of the Price Procurement Department of the National Healthcare Security Administration, stated that among the 27 batches of medical service price approval guidelines released in China, there are more than 100 new price items related to new products and equipment, including "artificial heart", "artificial cochlea", "artificial throat", etc. The medical insurance department closely monitors the new development of technological innovation in the medical field, focuses on new technologies and products urgently needed in clinical practice, fills the gap in diagnosis and treatment, and meets the needs of patients Jiang Bingzhen introduced that in order to meet the treatment needs of end-stage heart failure patients, the National Healthcare Security Administration has newly established three "artificial heart" related price items in the cardiovascular project guidelines, including the implantation fee and removal fee of auxiliary devices, to solve the charging problem of key links such as implantation and removal of "artificial hearts". Specifically, the overall cost of "artificial heart" implantation surgery has decreased from millions of yuan to around 700000 yuan. On April 1st, the Tianjin Medical Insurance Bureau took the lead in coordinating and implementing government guidance prices, including a placement fee of 13000 yuan and a withdrawal fee of 6500 yuan. According to public information, there are approximately 27.8 million people with hearing disabilities in China. With the deepening of aging, the size of this group is still expanding, and hearing problems have attracted much attention. Currently, cochlear implantation is an effective method for treating severe, extremely severe, and even total deafness. Starting from March 2025, various regions across the country will implement the national policy of centralized procurement and selection of medical consumables for cochlear implants. The average price per set will be reduced from 210000 yuan to around 50000 yuan, greatly lowering the economic threshold for cochlear implant treatment. The National Healthcare Security Administration has set up price items such as "cochlear implant" fees, removal fees, and adaptation fees in the guidelines for ear, nose, and throat projects. At the same time, abnormal cochlear implants are included as an additional charge, and medical institutions are encouraged to provide high-quality services for patients with complex conditions. In addition, the newly added price items also involve artificial valve equipment, proton radiation therapy technology, brain computer interfaces, etc. Medical insurance is not only a livelihood work, but also an economic work; It is both a bottom line guarantee and an innovation leader; It is both a paying department and an empowering department Jiang Bingzhen said that the National Healthcare Security Administration will continue to uphold an open attitude, smooth the green channel for high-level new technology price projects, promote innovative achievements that meet the urgent needs of patients, accelerate their entry into clinical practice, timely obtain returns, empower the healthy and orderly development of emerging health industries, and better adapt to the trend of public medical needs and clinical technology progress. (New Society)